Nimotuzumab significantly increases survival rate in head and neck cancer, claims Tata Memorial study

Jul 30, 2024

A study conducted by Tata Memorial Hospital in Mumbai has shown that adding Nimotuzumab to the standard treatment regimen significantly improves the 10-year overall...